No record found
No record found
No record found
capitalstake.com. Provided by * Returns not adjusted for payouts
^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.
Company Profile
Haleon Pakistan Limited (formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited) was incorporated in Pakistan as a public listed company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on 31 March 2015. The Company is a subsidiary of ‘Haleon Netherlands B.V’. The ultimate parent of the Company is Haleon plc. The Company is inter alia principally engaged in the manufacturing, marketing and sale of consumer healthcare and over the counter health products.
| Qawi Naseer | CEO |
| Farhan Muhammad Haroon | Chairperson |
| Mashal Mohammad | Company Secretary |
11-A, 11th Floor, Sky Tower (East Wing), Dolmen City, HC-3, Block 4, Scheme-5, Clifton, Karachi, 75600
CDC Share Registrar Services Limited CDC House, Main Shahrah-e-Faisal, Karachi.
M/s KPMG Taseer Hadi & Co. Chartered Accountants
December
Equity Profile
Announcements
| Date | Title | Document |
|---|---|---|
| Aug 28, 2026 | Transmission of Quarterly Report for the Period Ended 30 June 2026 | View PDF |
| Aug 27, 2026 | Financial Results for the Quarter Ended 30 June 2026 | View PDF |
| Apr 30, 2026 | Transmission of Quarterly Report for the Period Ended 31 March 2026 | View PDF |
| Apr 29, 2026 | Financial Results for the Quarter Ended 31 March 2026 | View PDF |
| Apr 7, 2026 | Transmission of Annual Report for the Year Ended 2025 | View PDF |
| Date | Title | Document |
|---|---|---|
| Aug 20, 2026 | Notice of Board of Directors Meeting - (Q2-2026) | View PDF |
| Apr 28, 2026 | CTC of Resolutions Passed in the Annual General Meeting 2025 | View PDF |
| Apr 21, 2026 | Notice of Board of Directors Meeting - (Q1-2026) | View PDF |
| Apr 7, 2026 | Notice of Annual General Meeting | View PDF |
| Apr 6, 2026 | Prior Publication of Annual General Meeting Notice | View PDF |
| Date | Title | Document |
|---|---|---|
| Sep 1, 2026 | Notice of Interim Cash Dividend and Share Book Closure | View PDF |
| Aug 31, 2026 | Prior Publication of Notice of Interim Cash Dividend and Share Book Closure | View PDF |
| Aug 28, 2026 | Annual Environment Excellence Award 2026 by the National Forum for Environment & Health (NFEH) | View PDF |
| Aug 27, 2026 | Change of Head of Internal Audit | View PDF |
| Jun 11, 2026 | Reminder for Conversion of Physical Shares to Book Entry Form & Unclaimed Dividend(s) / Share Certificates | View PDF |
Financials
All numbers in thousands (000's) except EPS
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 43,106,420 | 37,205,893 | 31,609,776 | 27,507,212 |
| Profit after Taxation | 6,373,151 | 4,578,247 | 995,586 | 325,411 |
| EPS | 54.45 | 39.11 | 8.51 | 2.78 |
| Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | |
|---|---|---|---|---|
| Sales | 10,072,084 | 9,593,810 | 10,562,883 | 11,598,087 |
| Profit after Taxation | 1,676,199 | 1,524,759 | 1,615,006 | 1,623,159 |
| EPS | 14.32 | 13.03 | 13.80 | 13.87 |

Ratios
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Gross Profit Margin (%) | 39.09 | 34.45 | 20.40 | 17.40 |
| Net Profit Margin (%) | 14.78 | 12.31 | 3.15 | 1.18 |
| EPS Growth (%) | 39.22 | 359.58 | 206.12 | (84.75) |
| PEG | 0.39 | 0.06 | 0.10 | (0.70) |









Feedback
Terms of Use
https://www.psx.com.pk